Provided by Tiger Trade Technology Pte. Ltd.

YieldMax HIMS Option Income Strategy ETF

11.47
-0.0808-0.70%
Post-market: 11.470.00000.00%19:49 EDT
Volume:29.93K
Turnover:346.82K
Market Cap:12.90M
PE:- -
High:11.84
Open:11.72
Low:11.35
Close:11.55
52wk High:53.97
52wk Low:9.53
Shares:1.13M
Float Shares:1.13M
Volume Ratio:1.09
T/O Rate:2.66%
Dividend:17.23
Dividend Rate:150.20%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

U.S. RESEARCH ROUNDUP- Datadog, Jabil, Prologis

Reuters
·
Jun 18

Barclays Keeps Their Buy Rating on Hims & Hers Health (HIMS)

TIPRANKS
·
Jun 18

Hims & Hers CTO Mohamed Elshenawy disposes of USD 1.42 million in common shares

Reuters
·
Jun 18

Hims & Hers price target raised to $39 from $29 at Barclays

TIPRANKS
·
Jun 18

Hims & Hers Stands to Get a Big Chunk of the $2.2B Peptides Market -- Barrons.com

Dow Jones
·
Jun 17

BUZZ-U.S. STOCKS ON THE MOVE-Qualcomm, Robinhood, Mobileye

Reuters
·
Jun 16

BUZZ-Leerink sees about $440 million peptide revenue chance for Hims & Hers

Reuters
·
Jun 16

Hims & Hers files initial beneficial ownership statement for new director Kofi Owusu Amoo-Gottfried

Reuters
·
Jun 16

Hims & Hers Health holds annual shareholder meeting, directors elected

Reuters
·
Jun 16

Moderately bullish activity in Hims and Hers Health with shares up 10.7%

TIPRANKS
·
Jun 16

What Hims & Hers Health (HIMS)'s Eucalyptus Deal and Longevity Push Means For Shareholders

Simply Wall St.
·
Jun 13

Moderately bullish activity in Hims and Hers Health with shares up 1.47%

TIPRANKS
·
Jun 10

Skip the Oura Ring IPO. Buy These 10 Stocks Instead.

InvestorPlace
·
Jun 07

Cboe data shows mixed options sentiment in Hims and Hers Health with shares up 5.0%

TIPRANKS
·
Jun 05

Hims & Hers names Dr. Anant Vinjamoori chief medical officer of Hims brand

Reuters
·
Jun 04

Hims & Hers Names DR. Anant Vinjamoori as Chief Medical Officer of Hims

THOMSON REUTERS
·
Jun 04

BUZZ-U.S. STOCKS ON THE MOVE-Ollie's Bargain Outlet Holdings, Steel Dynamics

Reuters
·
Jun 03

BUZZ-U.S. STOCKS ON THE MOVE-GameStop, Gitlab, T1 Energy

Reuters
·
Jun 03

BUZZ-US FDA's peptide classification review could expand Hims & Hers' market share, Canaccord says

Reuters
·
Jun 03

Sector Update: Healthcare

MT Newswires Live
·
Jun 02